AXON — Axon Enterprise Balance Sheet
0.000.00%
- $51.80bn
- $51.32bn
- $1.56bn
Annual balance sheet for Axon Enterprise, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 351 | 562 | 443 | 975 | 1,321 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 185 | 293 | 501 | 555 | 693 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 609 | 982 | 1,109 | 1,805 | 2,397 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 43.8 | 128 | 162 | 208 | 237 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 846 | 1,381 | 1,688 | 2,852 | 3,437 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 196 | 256 | 419 | 603 | 800 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 302 | 405 | 640 | 1,583 | 1,825 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 543 | 976 | 1,048 | 1,268 | 1,612 |
Total Liabilities & Shareholders' Equity | 846 | 1,381 | 1,688 | 2,852 | 3,437 |
Total Common Shares Outstanding |